Sensitization of DNA damage–induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3σ and survivin
Proteasome inhibition following DNA damage results in the synergistic induction of apoptosis via a nuclear factor-κB–independent mechanism. In this study, we identify the role of p53 in mediating apoptosis by the sequence-specific treatment involving the DNA-damaging, topoisomerase I–targeting drug...
Gespeichert in:
Veröffentlicht in: | Molecular cancer therapeutics 2005-12, Vol.4 (12), p.1880-1890 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Proteasome inhibition following DNA damage results in the synergistic induction of apoptosis via a nuclear factor-κB–independent
mechanism. In this study, we identify the role of p53 in mediating apoptosis by the sequence-specific treatment involving
the DNA-damaging, topoisomerase I–targeting drug SN-38 followed by the proteasome inhibitor PS-341 (SN-38→PS-341). The p53-dependent
sensitization of DNA damage–induced apoptosis by PS-341 is accompanied by persistent inhibition of proteasome activity and
increased cytosolic accumulation of p53, including higher molecular weight forms likely representing ubiquitinated species.
In contrast, pretreatment with PS-341 followed by treatment with SN-38 (PS-341→SN-38), which leads to an antagonistic interaction,
results in transient inhibition of proteasome activity and accumulation of significantly lower levels of p53 localized primarily
to the nucleus. Whereas cells treated with PS-341→SN-38 undergo G 2 + M cell cycle arrest, cells treated with SN-38→PS-341 exhibit a decreased G 2 + M block with a concomitant increase in the sub-G 1 population. Decreased accumulation of cells in the G 2 + M phase of the cell cycle in SN-38→PS-341–treated cells compared with PS-341→SN-38–treated cells correlates with enhanced
apoptosis and reduced expression of two p53-modulated proteins, 14-3-3σ and survivin, both of which play critical roles in
regulating G 2 + M progression and apoptosis. The functional role of 14-3-3σ or survivin in regulating the divergent function of p53 in
response to SN-38→PS-341 and PS-341→SN-38 treatment in inducing apoptosis versus G 2 + M arrest/DNA repair, respectively, was confirmed by targeted down-regulation of these proteins. These results provide insights
into the mechanisms by which inhibition of proteasome activity modulates DNA damage–induced apoptosis via a p53-dependent
pathway. [Mol Cancer Ther 2005;4(12):1880–90] |
---|---|
ISSN: | 1535-7163 1538-8514 |
DOI: | 10.1158/1535-7163.MCT-05-0222 |